FinanceORIC Pharmaceuticals, Inc. (ORIC) Secures $125M to Advance ORIC-944 Phase 3 Trials Saipriya pradhan4 days ago01 mins Post Content Yahoo Finance Post navigation Previous: EPFO 3.0, Form 16 & other money changes in JuneNext: PepGen Inc. (PEPG) Halts DMD Program After Trial Miss; Shifts Focus to DM1 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
ETFs are outpacing mutual funds despite market volatility. Are rookie retail investors at risk? Saipriya pradhan2 minutes ago 0
Report casts doubt on Labour’s ability to hit affordable housing target Saipriya pradhan2 minutes ago 0
Drugmaker Indivior to abandon London listing amid exodus of companies Saipriya pradhan2 minutes ago 0